Barrow, Hanley, Mewhinney & Strauss’s ChampionX CHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-472
Closed -$16.9K 308
2024
Q1
$16.9K Buy
472
+26
+6% +$778 ﹤0.01% 144
2023
Q4
$13K Buy
+446
New +$13.8K ﹤0.01% 162
2023
Q3
Sell
-105
Closed -$3.26K 290
2023
Q2
$3.26K Hold
105
﹤0.01% 233
2023
Q1
$2.85K Hold
105
﹤0.01% 250
2022
Q4
$3.04K Hold
105
﹤0.01% 239
2022
Q3
$2K Hold
105
﹤0.01% 252
2022
Q2
$2K Buy
105
+23
+28% +$520 ﹤0.01% 250
2022
Q1
$2K Sell
82
-1,057
-93% -$24.5K ﹤0.01% 280
2021
Q4
$23K Buy
+1,139
New +$26.8K ﹤0.01% 298
2021
Q3
Sell
-979
Closed -$25K 321
2021
Q2
$25K Buy
+979
New +$23.8K ﹤0.01% 278

Other funds holding CHX

Barrow, Hanley, Mewhinney & Strauss's CHX Position: Q2 2024 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of ChampionX (CHX) in Q2 2024, closing a stake of 472 shares — an estimated $16.9K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in CHX in Q2 2021 and held it in 10 quarters. The position peaked at $25K in Q2 2021. 432 funds tracked by Wall St. Rank hold CHX as of Q2 2024.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining ChampionX position as of Q2 2024 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 472 ChampionX shares in Q2 2024, an estimated $16.9K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in ChampionX in Q2 2021 and held it in 10 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's ChampionX position peaked at $25K in Q2 2021.
  • 432 funds tracked by Wall St. Rank held ChampionX as of Q2 2024.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q2 2024, filed 13 Aug 2024.